607 related articles for article (PubMed ID: 27362975)
1. Short-acting insulin analogues versus regular human insulin for adults with type 1 diabetes mellitus.
Fullerton B; Siebenhofer A; Jeitler K; Horvath K; Semlitsch T; Berghold A; Plank J; Pieber TR; Gerlach FM
Cochrane Database Syst Rev; 2016 Jun; 2016(6):CD012161. PubMed ID: 27362975
[TBL] [Abstract][Full Text] [Related]
2. Short-acting insulin analogues versus regular human insulin for adult, non-pregnant persons with type 2 diabetes mellitus.
Fullerton B; Siebenhofer A; Jeitler K; Horvath K; Semlitsch T; Berghold A; Gerlach FM
Cochrane Database Syst Rev; 2018 Dec; 12(12):CD013228. PubMed ID: 30556900
[TBL] [Abstract][Full Text] [Related]
3. (Ultra-)long-acting insulin analogues for people with type 1 diabetes mellitus.
Hemmingsen B; Metzendorf MI; Richter B
Cochrane Database Syst Rev; 2021 Mar; 3(3):CD013498. PubMed ID: 33662147
[TBL] [Abstract][Full Text] [Related]
4. Subcutaneous rapid-acting insulin analogues for diabetic ketoacidosis.
Andrade-Castellanos CA; Colunga-Lozano LE; Delgado-Figueroa N; Gonzalez-Padilla DA
Cochrane Database Syst Rev; 2016 Jan; 2016(1):CD011281. PubMed ID: 26798030
[TBL] [Abstract][Full Text] [Related]
5. (Ultra-)long-acting insulin analogues versus NPH insulin (human isophane insulin) for adults with type 2 diabetes mellitus.
Semlitsch T; Engler J; Siebenhofer A; Jeitler K; Berghold A; Horvath K
Cochrane Database Syst Rev; 2020 Nov; 11(11):CD005613. PubMed ID: 33166419
[TBL] [Abstract][Full Text] [Related]
6. Short acting insulin analogues versus regular human insulin in patients with diabetes mellitus.
Siebenhofer A; Plank J; Berghold A; Jeitler K; Horvath K; Narath M; Gfrerer R; Pieber TR
Cochrane Database Syst Rev; 2006 Apr; (2):CD003287. PubMed ID: 16625575
[TBL] [Abstract][Full Text] [Related]
7. Intensive glucose control versus conventional glucose control for type 1 diabetes mellitus.
Fullerton B; Jeitler K; Seitz M; Horvath K; Berghold A; Siebenhofer A
Cochrane Database Syst Rev; 2014 Feb; 2014(2):CD009122. PubMed ID: 24526393
[TBL] [Abstract][Full Text] [Related]
8. Insulin secretagogues for prevention or delay of type 2 diabetes mellitus and its associated complications in persons at increased risk for the development of type 2 diabetes mellitus.
Hemmingsen B; Sonne DP; Metzendorf MI; Richter B
Cochrane Database Syst Rev; 2016 Oct; 10(10):CD012151. PubMed ID: 27749986
[TBL] [Abstract][Full Text] [Related]
9. Short acting insulin analogues versus regular human insulin in patients with diabetes mellitus.
Siebenhofer A; Plank J; Berghold A; Narath M; Gfrerer R; Pieber TR
Cochrane Database Syst Rev; 2004 Oct; (4):CD003287. PubMed ID: 15495047
[TBL] [Abstract][Full Text] [Related]
10. Short acting insulin analogues versus regular human insulin in patients with diabetes mellitus.
Siebenhofer A; Plank J; Berghold A; Narath M; Gfrerer R; Pieber TR
Cochrane Database Syst Rev; 2004; (2):CD003287. PubMed ID: 15106199
[TBL] [Abstract][Full Text] [Related]
11. Sliding scale insulin for non-critically ill hospitalised adults with diabetes mellitus.
Colunga-Lozano LE; Gonzalez Torres FJ; Delgado-Figueroa N; Gonzalez-Padilla DA; Hernandez AV; Roman Y; Cuello-García CA
Cochrane Database Syst Rev; 2018 Nov; 11(11):CD011296. PubMed ID: 30488948
[TBL] [Abstract][Full Text] [Related]
12. Sulphonylurea monotherapy for patients with type 2 diabetes mellitus.
Hemmingsen B; Schroll JB; Lund SS; Wetterslev J; Gluud C; Vaag A; Sonne DP; Lundstrøm LH; Almdal T
Cochrane Database Syst Rev; 2013 Apr; (4):CD009008. PubMed ID: 23633364
[TBL] [Abstract][Full Text] [Related]
13. Insulin monotherapy compared with the addition of oral glucose-lowering agents to insulin for people with type 2 diabetes already on insulin therapy and inadequate glycaemic control.
Vos RC; van Avendonk MJ; Jansen H; Goudswaard AN; van den Donk M; Gorter K; Kerssen A; Rutten GE
Cochrane Database Syst Rev; 2016 Sep; 9(9):CD006992. PubMed ID: 27640062
[TBL] [Abstract][Full Text] [Related]
14. Long-acting insulin analogues versus NPH insulin (human isophane insulin) for type 2 diabetes mellitus.
Horvath K; Jeitler K; Berghold A; Ebrahim SH; Gratzer TW; Plank J; Kaiser T; Pieber TR; Siebenhofer A
Cochrane Database Syst Rev; 2007 Apr; (2):CD005613. PubMed ID: 17443605
[TBL] [Abstract][Full Text] [Related]
15. Intermediate acting versus long acting insulin for type 1 diabetes mellitus.
Vardi M; Jacobson E; Nini A; Bitterman H
Cochrane Database Syst Rev; 2008 Jul; 2008(3):CD006297. PubMed ID: 18646147
[TBL] [Abstract][Full Text] [Related]
16. Effect of insulin analogues on risk of severe hypoglycaemia in patients with type 1 diabetes prone to recurrent severe hypoglycaemia (HypoAna trial): a prospective, randomised, open-label, blinded-endpoint crossover trial.
Pedersen-Bjergaard U; Kristensen PL; Beck-Nielsen H; Nørgaard K; Perrild H; Christiansen JS; Jensen T; Hougaard P; Parving HH; Thorsteinsson B; Tarnow L
Lancet Diabetes Endocrinol; 2014 Jul; 2(7):553-61. PubMed ID: 24794703
[TBL] [Abstract][Full Text] [Related]
17. Targeting intensive glycaemic control versus targeting conventional glycaemic control for type 2 diabetes mellitus.
Hemmingsen B; Lund SS; Gluud C; Vaag A; Almdal TP; Hemmingsen C; Wetterslev J
Cochrane Database Syst Rev; 2013 Nov; (11):CD008143. PubMed ID: 24214280
[TBL] [Abstract][Full Text] [Related]
18. Insulin aspart: a review of its use in the management of type 1 and 2 diabetes mellitus.
Chapman TM; Noble S; Goa KL
Drugs; 2002; 62(13):1945-81. PubMed ID: 12215068
[TBL] [Abstract][Full Text] [Related]
19. Inhaled insulin in diabetes mellitus.
Royle P; Waugh N; McAuley L; McIntyre L; Thomas S
Cochrane Database Syst Rev; 2003; (3):CD003890. PubMed ID: 12917994
[TBL] [Abstract][Full Text] [Related]
20. Inhaled insulin in diabetes mellitus.
Royle P; Waugh N; McAuley L; McIntyre L; Thomas S
Cochrane Database Syst Rev; 2004; (3):CD003890. PubMed ID: 15266506
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
